Feed/Companies/Solve Therapeutics

Solve Therapeutics

As of 14 Oct 2026, Solve Therapeutics has raised $120M across 1 verified round on record; latest: $120 million funding round led by Yosemite, announced 17 Nov 2025.

BUILT ON

Visit site

Novel antibody-drug conjugates (ADCs) for cancer treatment targeted at solid tumors and optimized for payload delivery using proprietary technology.

solvetx.comSan Diego, CABiotech

LATEST ROUND

Funding round

$120M · 2025-11-17

RAISED ON RECORD · USD

$120M

across 1 verified round

INVESTORS

1 lead

SOURCES

from 1 publisher

Rounds

Feed/Companies

Company

Every round on record, with the sources behind each and the investors on them.

BUILT ON

Funding round

$120M · 2025-11-17

[ HISTORY ]

led by Yosemite

Round	Amount	Announced	Lead	Buzz
Funding round [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$120M	2025-11-17	Yosemite	No recent discussion
1 source [ VERIFIED ] read against 1 source The release mentions $321 million in total capital raised, but that is total capital to date, not this round’s financing total.

Solve Therapeutics

Rounds

Company

Rounds

Sources

Profile

Investors

Solve Therapeutics

Rounds

Profile

Sources

Funding round$120M2025-11-171 source

Investors

Funding round$120M2025-11-1712 investors